Wells Fargo & Company View Ray, Inc. Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$0.35 - $3.28 $39,858 - $373,532	113,882 Added 35.59%	433,884 $151,000
Q1 2023 May 12, 2023	BUY	$3.28 - $4.81 $61,595 - $90,326	18,779 Added 6.23%	320,002 $1.11 Million
Q4 2022 Feb 13, 2023	SELL	$3.65 - $4.82 $7,774 - $10,266	-2,130 Reduced 0.7%	301,223 $1.35 Million
Q3 2022 Nov 14, 2022	SELL	$2.66 - $3.97 $5,394 - $8,051	-2,028 Reduced 0.66%	303,353 $1.11 Million
Q2 2022 Aug 12, 2022	SELL	$2.42 - $4.05 $266,052 - $445,252	-109,939 Reduced 26.47%	305,381 $808,000
Q1 2022 May 16, 2022	SELL	$3.45 - $5.83 $139,521 - $235,771	-40,441 Reduced 8.87%	415,320 $1.63 Million
Q4 2021 Feb 14, 2022	SELL	$4.89 - $7.59 $2.03 Million - $3.15 Million	-415,365 Reduced 47.68%	455,761 $2.51 Million
Q3 2021 Nov 15, 2021	BUY	$5.18 - $7.41 $2.47 Million - $3.53 Million	476,204 Added 120.58%	871,126 $6.28 Million
Q2 2021 Aug 16, 2021	BUY	$3.94 - $6.75 $222,271 - $380,794	56,414 Added 16.67%	394,922 $2.61 Million
Q1 2021 May 13, 2021	SELL	$4.03 - $7.25 $701,651 - $1.26 Million	-174,107 Reduced 33.96%	338,508 $1.47 Million
Q4 2020 Feb 09, 2021	BUY	$2.78 - $4.5 $125,511 - $203,166	45,148 Added 9.66%	512,615 $1.96 Million
Q3 2020 Nov 05, 2020	SELL	$2.12 - $3.53 $115,713 - $192,674	-54,582 Reduced 10.46%	467,467 $1.64 Million
Q2 2020 Aug 13, 2020	BUY	$1.66 - $2.73 $332,330 - $546,543	200,199 Added 62.2%	522,049 $1.17 Million
Q1 2020 May 14, 2020	BUY	$1.35 - $4.05 $434,497 - $1.3 Million	321,850 New	321,850 $805,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.